120 related articles for article (PubMed ID: 15753994)
1. Proteome-based identification of molecular markers predicting chemosensitivity to each category of anticancer agents in human gliomas.
Iwadate Y; Sakaida T; Saegusa T; Hiwasa T; Takiguchi M; Fujimoto S; Yamaura A
Int J Oncol; 2005 Apr; 26(4):993-8. PubMed ID: 15753994
[TBL] [Abstract][Full Text] [Related]
2. Molecular classification and survival prediction in human gliomas based on proteome analysis.
Iwadate Y; Sakaida T; Hiwasa T; Nagai Y; Ishikura H; Takiguchi M; Yamaura A
Cancer Res; 2004 Apr; 64(7):2496-501. PubMed ID: 15059904
[TBL] [Abstract][Full Text] [Related]
3. Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis.
Gollapalli K; Ghantasala S; Atak A; Rapole S; Moiyadi A; Epari S; Srivastava S
OMICS; 2017 May; 21(5):275-284. PubMed ID: 28481733
[TBL] [Abstract][Full Text] [Related]
4. [Chemosensitivity assays for malignant gliomas].
Sasaoka N
Gan To Kagaku Ryoho; 1990 Nov; 17(11):2247-52. PubMed ID: 2241189
[TBL] [Abstract][Full Text] [Related]
5. Differential chemosensitivity in human intracerebral gliomas measured by flow cytometric DNA analysis.
Iwadate Y; Fujimoto S; Yamaura A
Int J Mol Med; 2002 Aug; 10(2):187-92. PubMed ID: 12119557
[TBL] [Abstract][Full Text] [Related]
6. Expression of p33ING1 mRNA and chemosensitivity in brain tumor cells.
Tallen G; Riabowol K; Wolff JE
Anticancer Res; 2003; 23(2B):1631-5. PubMed ID: 12820433
[TBL] [Abstract][Full Text] [Related]
7. Proteomic comparison of oligodendrogliomas with and without 1pLOH.
Okamoto H; Li J; Gläsker S; Vortmeyer AO; Jaffe H; Robison RA; Bogler O; Mikkelsen T; Lubensky IA; Oldfield EH; Zhuang Z
Cancer Biol Ther; 2007 Mar; 6(3):391-6. PubMed ID: 17264672
[TBL] [Abstract][Full Text] [Related]
8. Prediction of drug cytotoxicity in 9L rat brain tumor by using flow cytometry with a deoxyribonucleic acid-binding dye.
Iwadate Y; Fujimoto S; Sueyoshi K; Namba H; Tagawa M; Yamaura A
Neurosurgery; 1997 Apr; 40(4):782-7; discussion 787-8. PubMed ID: 9092852
[TBL] [Abstract][Full Text] [Related]
9. Expression pattern of chemoresistance-related genes in human malignant brain tumors: a working knowledge for proper selection of anticancer drugs.
Nagane M; Asai A; Shibui S; Oyama H; Nomura K; Kuchino Y
Jpn J Clin Oncol; 1999 Nov; 29(11):527-34. PubMed ID: 10678554
[TBL] [Abstract][Full Text] [Related]
10. A unique four-hub protein cluster associates to glioblastoma progression.
Simeone P; Trerotola M; Urbanella A; Lattanzio R; Ciavardelli D; Di Giuseppe F; Eleuterio E; Sulpizio M; Eusebi V; Pession A; Piantelli M; Alberti S
PLoS One; 2014; 9(7):e103030. PubMed ID: 25050814
[TBL] [Abstract][Full Text] [Related]
11. Alteration of CDKN2/p16 in human astrocytic tumors is related with increased susceptibility to antimetabolite anticancer agents.
Iwadate Y; Mochizuki S; Fujimoto S; Namba H; Sakiyama S; Tagawa M; Yamaura A
Int J Oncol; 2000 Sep; 17(3):501-5. PubMed ID: 10938390
[TBL] [Abstract][Full Text] [Related]
12. Molecular profiling of gliomas: potential therapeutic implications.
Alentorn A; Duran-Peña A; Pingle SC; Piccioni DE; Idbaih A; Kesari S
Expert Rev Anticancer Ther; 2015; 15(8):955-62. PubMed ID: 26118895
[TBL] [Abstract][Full Text] [Related]
13. Knockdown ATG4C inhibits gliomas progression and promotes temozolomide chemosensitivity by suppressing autophagic flux.
Wen ZP; Zeng WJ; Chen YH; Li H; Wang JY; Cheng Q; Yu J; Zhou HH; Liu ZZ; Xiao J; Chen XP
J Exp Clin Cancer Res; 2019 Jul; 38(1):298. PubMed ID: 31291988
[TBL] [Abstract][Full Text] [Related]
14. Glioma cells escaped from cytotoxicity of temozolomide and vincristine by communicating with human astrocytes.
Chen W; Wang D; Du X; He Y; Chen S; Shao Q; Ma C; Huang B; Chen A; Zhao P; Qu X; Li X
Med Oncol; 2015 Mar; 32(3):43. PubMed ID: 25631631
[TBL] [Abstract][Full Text] [Related]
15. MiR-873 acts as a novel sensitizer of glioma cells to cisplatin by targeting Bcl-2.
Chen X; Zhang Y; Shi Y; Lian H; Tu H; Han S; Peng B; Liu W; He X
Int J Oncol; 2015 Oct; 47(4):1603-11. PubMed ID: 26323558
[TBL] [Abstract][Full Text] [Related]
16. Association of p53 gene mutation with decreased chemosensitivity in human malignant gliomas.
Iwadate Y; Fujimoto S; Tagawa M; Namba H; Sueyoshi K; Hirose M; Sakiyama S
Int J Cancer; 1996 Jun; 69(3):236-40. PubMed ID: 8682593
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of microRNA-127 reverses adriamycin resistance via cell cycle arrest and apoptosis sensitization in adriamycin-resistant human glioma cells.
Feng R; Dong L
Int J Clin Exp Pathol; 2015; 8(6):6107-16. PubMed ID: 26261488
[TBL] [Abstract][Full Text] [Related]
18. PDCD5 promotes cisplatin-induced apoptosis of glioma cells via activating mitochondrial apoptotic pathway.
Li H; Zhang X; Song X; Zhu F; Wang Q; Guo C; Liu C; Shi Y; Ma C; Wang X; Zhang L
Cancer Biol Ther; 2012 Jul; 13(9):822-30. PubMed ID: 22688731
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetic and proteomic analysis of synchronous malignant gliomas.
Zhuang Z; Lee YS; Zeng W; Furuta M; Valyi-Nagy T; Johnson MD; Vnencak-Jones CL; Woltjer RL; Weil RJ
Neurology; 2004 Jun; 62(12):2316-9. PubMed ID: 15210906
[TBL] [Abstract][Full Text] [Related]
20. Chemosensitivity of human malignant glioma: modulation by p53 gene transfer.
Trepel M; Groscurth P; Malipiero U; Gulbins E; Dichgans J; Weller M
J Neurooncol; 1998 Aug; 39(1):19-32. PubMed ID: 9760067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
